Alain Labelle
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Safety of Adjunct Low-Dose Methylphenidate Extended-Release for Cognitive Deficits in Stable Schizophrenia: Results From an Open-Label, Randomized Crossover Trial.
Journal: Journal of clinical psychopharmacology
Published: January 20, 2026
Efficacy of Low-Dose Adjunctive Methylphenidate Extended-Release on Cognition and Functioning in Individuals With Schizophrenia: A Randomized Open-Label Trial.
Journal: Journal of clinical psychopharmacology
Published: July 28, 2025
Speech Mismatch Negativity (MMN) in Schizophrenia with Auditory Verbal Hallucinations.
Journal: Clinical EEG and neuroscience
Published: November 05, 2024
Adjunctive methylphenidate extended release in patients with schizophrenia: Protocol of a single-centre fixed dose cross-over open-label trial to improve functional and cognitive outcomes.
Journal: Contemporary clinical trials communications
Published: December 04, 2023
An α7 nAChR approach for the baseline-dependent modulation of deviance detection in schizophrenia: A pilot study assessing the combined effect of CDP-choline and galantamine.
Journal: Journal of psychopharmacology (Oxford, England)
Published: March 17, 2023
Comparison of Extrapyramidal Symptoms Among Outpatients With Schizophrenia on Long-Acting Injectable Antipsychotics.
Journal: Journal of clinical psychopharmacology
Published: August 17, 2022
The acute dose and baseline amplitude-dependent effects of CDP-choline on deviance detection (MMN) in chronic schizophrenia: A pilot study.
Journal: Experimental and clinical psychopharmacology
Published: February 25, 2021
Retrospective review of use of adjunctive psychostimulants in patients with schizophrenia.
Journal: Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists
Published: February 02, 2021
Alterations of Resting EEG in Hallucinating and Nonhallucinating Schizophrenia Patients.
Journal: Clinical EEG and neuroscience
Published: October 19, 2020
Interaction of Background Noise and Auditory Hallucinations on Phonemic Mismatch Negativity (MMN) and P3a Processing in Schizophrenia.
Journal: Frontiers in psychiatry
Published: March 06, 2020
Change in the Neural Response to Auditory Deviance Following Cognitive Therapy for Hallucinations in Patients With Schizophrenia.
Journal: Frontiers in psychiatry
Published: March 05, 2020
Combining CDP-choline and galantamine, an optimized α7 nicotinic strategy, to ameliorate sensory gating to speech stimuli in schizophrenia.
Journal: International journal of psychophysiology : official journal of the International Organization of Psychophysiology
Published: August 06, 2018
Last Updated: 09/26/2026